Member market on a chip | An interesting device used to feed internal organs with the help of silicone

Allied Market Research published a report titled “Member Market on a Chip By type (heart on chip, human on chip, gut on chip, kidney on chip, liver on chip, lung on chip): Global Opportunity Analysis and Industry Outlook, 2020-2030.According to the report, the global chip organ industry was valued at $103.44 million in 2020, and is expected to reach $1.6 billion by 2030, registering a compound annual growth rate of 31.1% from 2021 to 2030.

What is the estimated industry size for members on a chip?

The total market capitalization of the member-on-chip market is $103.44 million in 2020.

What is the leading application of the Organ-on-Chip Market?

The chip lung segment dominated the market in 2020, and is expected to remain dominant during the forecast period, due to the decline in lung transplants, resulting in the development of lab-designed chips to mimic their functions and screening of drugs for respiratory disorders and is expected to lead the segment.

Download a free sample PDF now (including full table of contents, table, and figures):

Value propositions related to the report:

  • Powered by free analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative insights at the sector and sub-segment level
  • COVID-19 Impact Trends and Perspectives
  • Accurate insights at the global / regional / country level
  • Deep-rooted insights into market dynamics (Drivers, Constraints, Opportunities) and the business environment
  • Comprehensive coverage of the competitive landscape
  • Winning inevitability
  • Comprehensive coverage on “strategic developments” recorded by major market players

Covid-19 case –

  • Organ-on-Chip emerged as a favorable technology for vaccine and drug development, which was under clinical trials. This, in turn, favorably affected the global market for organs for chips.
  • This trend is likely to continue until the epidemic is completely over.

Simply speak to the experts for further clarification [COVID-19 on Your Business}:

The lung on chip segment to maintain the dominant share –

Based on product, the lung segment holds more than one-fifth of the revenue in the global device-on-a-chip market in 2020 and is expected to lead way in the year 2030. Reduced lung turnover has led to the development. of on-a-chips designed in the laboratory to mimic their function. This makes the growth of the organ appear. The heart attack segment, on the other hand, will show the fastest CAGR of 32.8% from 2021 to 2030, due to the increase in heart problems among people across the world.

North America garnered the major share in 2020 –

Based on region, North America has the largest share in 2020, accounting for more than two-fifths of the global parts-on-chip market. This is due to the rapid adoption of advanced technology and the presence of major players across North America. The Asia-Pacific region, meanwhile, will see the fastest growth at a CAGR of 33.1% by 2030, due to increased R&D for the development of component-on-chip models.

Major Key Market Players in the Industry –

  • BICO Group AB(Visikol)
  • CN Bio Innovations Limited
  • Elveflow
  • Emulate, Inc.
  • AxoSim Technologies LLC
  • Nortis Inc.
  • Tara Biosystems
  • Organovo Holdings, Inc.
  • Insphero AG
  • Mimetas B.V.

Inquire More About the Top Key Market Players Here:

Market: By Region Outlook

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Africa, Turkey, Saudi Arabia, Rest of LAMEA)

Important Questions Being Answered by This Market Report Are –

Q1. What are the upcoming trends of Organ-on-Chip Market in the world?

Q2. Which are the top companies to hold the market share in Organ-on-Chip?

Q3. Which is the largest regional market for Organ-on-Chip?

Request for Customization:

Depending on type, the organ-on-chip market analysis lung-on-chip segment generated maximum revenue in 2020, accounting for $21.37 million. The heart-on-chip segment is expected to witness highest CAGR of 32.8% during the forecast period.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Leave a Reply

Your email address will not be published. Required fields are marked *